A5047122390- Hepatitis B Virus Studies
- Liver Disease Diagnosis and Treatment
- Breast Cancer Treatment Studies
- Hepatocellular Carcinoma Treatment and Prognosis
- Peptidase Inhibition and Analysis
- Childhood Cancer Survivors' Quality of Life
- Prostate Cancer Treatment and Research
- Renal cell carcinoma treatment
- HER2/EGFR in Cancer Research
- Hormonal and reproductive studies
- Family Support in Illness
Manisa Celal Bayar University
2021-2025
In this Turkish Oncology Group study, we aimed to evaluate the effectiveness of trastuzumab emtansine (TDM1) in adjuvant treatment early-stage human epidermal growth factor receptor-2 (HER2)-positive breast cancer with residual disease using real-life data. A total 13 centers participated study between September 2019 and October 2024. Patients HER2-positive who underwent surgery after completing neoadjuvant chemotherapy HER2-targeted therapies had invasive or axillary lymph nodes received...
Objective: The “centrality of events scale” (CES) was formed to determine what extent this localisation a traumatic memory is formed. CES used in study how overshadowed the cancer disease by fear COVID-19 patients or centralised cognitive trauma patient group. Materials and Methods: In first paragraph short 7-item CES, it written, “Please think about most stressful event your life”, then 3 options were given. These alternatives were: A) I am currently being treated here for my disease., B)...
Current therapies in oncology that offer a longer and better quality of life are leading to more cases where cancer chronic diseases coexist. Enzalutamide, second-generation anti-androgen agent, was approved by the US Food Drug Administration (FDA) 2012 for treatment metastatic castration-resistant prostate (mCRPC). There is no series with many patients on use enzalutamide end-stage renal disease (ESRD). We present patient diagnosed mCRPC who followed up about 5 years after progression...
Giriş ve Amaç: Hepatoselüler karsinom (HCC), kanserin yaygın bir nedenidir çoğu HCC hastasında altta yatan siroz vardır. Retrospektif olarak kliniğimizde takipli HCC'li hastalarını karakterize etmeyi, sağkalımı araştırmayı sağkalım için öngörücü faktörleri belirlemeyi amaçladık. Gereç Yöntemler: Manisa Celal Bayar Üniversitesi Tıbbi Onkoloji Polikliniğinde 2014-2019 yılları arasında teşhisi konan tüm hastalar geriye dönük çalışmaya kaydedildi. Genel Kaplan -Meier yöntemi kullanılarak...